CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.

The success of these COVID-19 vaccines is remarkable and was far from guaranteed. mRNA is incredibly delicate. Enzymes in the environment and in our bodies are quick to chop mRNA into pieces ...

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

Vaccine opponents and skeptics in charge of federal health agencies are restricting access to COVID shots that were a signature accomplishment of President Donald Trump’s first term.

According to doctors, immunity from previous vaccines wears off over time, activating exposure to Omicron immune responses. However, mRNA vaccines give adequate protection and adaptability, so it is ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.